# Safety and Effectiveness of GENOSS® DES in Patients With Multivessel Coronary Artery Disease

> **NCT06168305** · — · ENROLLING_BY_INVITATION · sponsor: **Genoss Co., Ltd.** · enrollment: 1000 (estimated)

## Conditions studied

- Percutaneous Coronary Intervention
- Multivessel Coronary Artery Disease

## Interventions

- **DEVICE:** GENOSS® DES Sirolimus Eluting Coronary Stent System

## Key facts

- **NCT ID:** NCT06168305
- **Lead sponsor:** Genoss Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-11-15
- **Primary completion:** 2028-02-28
- **Final completion:** 2028-02-28
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06168305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06168305, "Safety and Effectiveness of GENOSS® DES in Patients With Multivessel Coronary Artery Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06168305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*